Show simple item record

dc.contributor.authorWille-Jørgensen, P
dc.contributor.authorSyk, I
dc.contributor.authorSmedh, K
dc.contributor.authorLaurberg, S
dc.contributor.authorNielsen, D
dc.contributor.authorPetersen, S
dc.contributor.authorRenehan, Andrew G
dc.contributor.authorHorváth-Puhó, E
dc.contributor.authorPåhlman, L
dc.contributor.authorSørensen, H
dc.date.accessioned2018-06-30T14:23:04Z
dc.date.available2018-06-30T14:23:04Z
dc.date.issued2018
dc.identifier.citationEffect of more vs less frequent follow-up testing on overall and colorectal cancer-specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial. 2018, 319(20): 2095-2103 JAMAen
dc.identifier.issn1538-3598
dc.identifier.pmid29800179
dc.identifier.doi10.1001/jama.2018.5623
dc.identifier.urihttp://hdl.handle.net/10541/621085
dc.description.abstractIntensive follow-up of patients after curative surgery for colorectal cancer is common in clinical practice, but evidence of a survival benefit is limited.
dc.language.isoenen
dc.rightsArchived with thanks to JAMAen
dc.subject.meshAdult
dc.subject.meshAftercare
dc.subject.meshAged
dc.subject.meshCarcinoembryonic Antigen
dc.subject.meshColorectal Neoplasms
dc.subject.meshFemale
dc.subject.meshFollow-Up Studies
dc.subject.meshHumans
dc.subject.meshIntention to Treat Analysis
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshMortality
dc.subject.meshNeoplasm Recurrence, Local
dc.subject.meshNeoplasm Staging
dc.subject.meshProportional Hazards Models
dc.subject.meshSurvival Rate
dc.subject.meshTime Factors
dc.subject.meshTomography, X-Ray Computed
dc.titleEffect of more vs less frequent follow-up testing on overall and colorectal cancer-specific mortality in patients with stage II or III colorectal cancer: the COLOFOL randomized clinical trial.en
dc.typeArticleen
dc.contributor.departmentAbdominal Disease Center, Bispebjerg Hospital and Danish Colorectal Cancer Group, Copenhagen, Denmarken
dc.identifier.journalJAMAen
html.description.abstractIntensive follow-up of patients after curative surgery for colorectal cancer is common in clinical practice, but evidence of a survival benefit is limited.


This item appears in the following Collection(s)

Show simple item record